Market Tracker

04/17 6:05pm ET

Geron Corp (NASDAQ:GERN)

1.94
Data as of Apr 17
 -0.03 / -1.52%
Today’s Change
1.01
Today|||52-Week Range
7.79
-59.07%
Year-to-Date

Today’s Trading

Previous close1.97
Today’s open1.98
Day’s range1.91 - 2.02
Volume2,393,706
Average volume (3 months)6,515,082
Market cap$304.4M
Dividend yield--
Data as of 3:59pm ET, 04/17/2014

Growth & Valuation

Earnings growth (last year)+44.44%
Earnings growth (this year)+14.17%
Earnings growth (next 5 years)--
Revenue growth (last year)-52.64%
P/E ratioNM
Price/Sales474.30
Price/Book4.24

Competitors

 Today’s
change
Today’s
% change
OXFDOxford Immunotec Glo...+0.11+0.62%
VCYTVeracyte Inc-0.06-0.45%
GALTGalectin Therapeutic...+1.33+12.94%
TTHITransition Therapeut...+0.05+0.90%
Data as of 3:59pm ET, 04/17/2014

Financials

Next reporting dateApril 30, 2014
EPS forecast (this quarter)-$0.06
Annual revenue (last year)$1.3M
Annual profit (last year)-$38.4M
Net profit margin-2,991.35%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
John A. Scarlett
Chief Financial Officer, Treasurer &
Executive VP
Olivia K. Bloom
Corporate headquarters
Menlo Park, California

Forecasts